Virtual Connections

/wp-content/uploads/2020/05/Group-14-2.png
We’re bringing experts from across the country to you with a series of virtual educational events to help you and your loved ones live well with type 1 diabetes. Meet and learn from new speakers, engage with other families and individuals with T1D and expand your knowledge on topics important to you – all from the comfort of your own home. To stay up-to-date on the latest and greatest in T1D treatment options, view the educational resources provided by our national TypeOneNation Summit sponsors.

Virtual Events

Benaroya Research Institute Research Update: T Cell Edition

September 3rd | Time: 6:00 pm PT

Speaker: Dr. Alice Long and Dr. Eddie James, Benaroya Research Institute

What happens when T Cells go awry or are too tired? Join Dr. Alice Long and Dr. Eddie James from the Benaroya Research Institute at Virgina Mason for an evening of research focused on treatments for exhausted T cells and preserving healthy beta cell function.  Type 1 diabetes research is a primary focus of the Benaroya Research Institute at Virgina Mason which currently has over $6M in JDRF funded grants to support this incredible work.

Tune in here: On Zoom


Virtual TypeOneNation Summit

September 26th | Time: 12:00 – 4:00 pm ET
Speakers: T1D medical and scientific experts, ambassadors, social influencers and community members

JDRF’s Virtual TypeOneNation Summit will bring together the type 1 diabetes (T1D) community coast-to-coast for a day of education and interactive experiences.  You’ll have the opportunity to attend sessions on topics that matter most to you, interact with our lineup of powerful speakers, learn about the latest research advancements from T1D experts, visit with industry partners in the exhibition hall and connect with peers from across the country.  This interactive day of learning is for people of all ages and stages of life with T1D and their loved ones. No cost to attend!

Register today!  https://jdrf.6connex.com/event/typeonenationsummit/login

Thank You to Our Sponsors

Premier Sponsor

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Supporting Sponsors

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. Get Started Today



Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. 

 



For more than 30 years, Medtronic has been helping people with diabetes.

Medtronic is working with the global community to change the way people manage diabetes. Together, we will transform diabetes care by expanding access, integrating care and improving outcomes, so people with diabetes can enjoy greater freedom and better health. 



Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone-related disorders, and obesity. 



Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. 



At Xeris, we believe that easy-to-use medicines can have a profound impact on the lives of patients and their families. That’s why we’re studying ready-to-use liquid glucagon, but that’s just the beginning. Learn how our technology is unlocking the potential of today’s medicines.